Rapid recurrence of ANCA-negative pauci-immune vasculitis after cadaveric renal transplantation.

We report a patient with renal failure secondary to antineutrophil cytoplasmic autoantibody (ANCA)-negative pauci-immune systemic vasculitis who developed rapid recurrence of vasculitis involving skin, eye, and kidney allograft 1 month after cadaveric renal transplant while being maintained on cyclosporine, mycophenolate mofetil, and prednisolone. Despite early institution of aggressive treatment with plasma exchange, the disease remained uncontrolled and resulted in substantial morbidity and subsequent graft failure within 1 year post-transplantation. This case confirms that ANCA-negative vasculitides may recur in transplanted patients taking mycophenolate mofetil. Transplantation is contraindicated when active disease is evident.

[1]  B. Cohen,et al.  Pauci-immune renal vasculitis: natural history, prognostic factors, and impact of therapy. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  P. Limburg,et al.  Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. , 2000, Arthritis and rheumatism.

[3]  R. Falk,et al.  ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective. , 2000, Seminars in nephrology.

[4]  M. Denton,et al.  Recurrent and de novo glomerulonephritis in the renal allograft. , 2000, Seminars in nephrology.

[5]  R. Falk,et al.  Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis. , 1999, Kidney international.

[6]  R. Ouseph,et al.  Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). , 1999, Transplantation.

[7]  K. Budde,et al.  Treatment of acute c-ANCA-positive vasculitis with mycophenolate mofetil. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  K. Andrassy,et al.  Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. , 1999, Journal of the American Society of Nephrology : JASN.

[9]  J. Fink,et al.  Risk for posttransplant Diabetes mellitus with current immunosuppressive medications. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  E. Hachulla,et al.  Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis. , 1999, The American journal of medicine.

[11]  C. Pusey,et al.  Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. , 1998, Journal of the American Society of Nephrology : JASN.

[12]  J. Ranstam,et al.  Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. , 1998, Journal of the American Society of Nephrology : JASN.

[13]  M. Haubitz,et al.  Renal transplantation for patients with autoimmune diseases: single-center experience with 42 patients. , 1997, Transplantation.

[14]  G. Nyberg,et al.  Systemic vasculitis in a kidney transplant population. , 1997, Transplantation.

[15]  S. Knechtle,et al.  Single-center experience with renal transplantation in patients with Wegener's granulomatosis , 1997, Transplant international : official journal of the European Society for Organ Transplantation.

[16]  L. Rostaing,et al.  Outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis following cadaveric kidney transplantation. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  G. Nyberg,et al.  Original renal disease in a kidney-transplant population. , 1995, Scandinavian journal of urology and nephrology.

[18]  K. Lai,et al.  Microscopic polyarteritis has a poor prognosis in Chinese. , 1995, The Journal of rheumatology.

[19]  C. Pusey,et al.  ANCA and predicting relapse in systemic vasculitis. , 1995, QJM : monthly journal of the Association of Physicians.

[20]  C. Wanner,et al.  Clinical course of patients with antineutrophil cytoplasm antibody positive vasculitis after kidney transplantation. , 1995, Nephron.

[21]  M. Haubitz,et al.  Lethal relapse of Wegener's disease 4 years after successful kidney transplantation. , 1995, Nephron.

[22]  J. Main,et al.  Rapid catastrophic onset of Wegener's granulomatosis in a renal transplant. , 1994, Nephron.

[23]  C. Hallahan,et al.  Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. , 1993, Arthritis and rheumatism.

[24]  G. Banfi,et al.  Late recurrence of systemic vasculitis after kidney transplantation involving the kidney allograft. , 1993, Advances in experimental medicine and biology.

[25]  K. Lai,et al.  Crescentic glomerulonephritis related to hepatitis B virus. , 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[26]  J. Esdaile,et al.  Treatment of Wegener's granulomatosis after renal transplantation: is cyclosporine the preferred treatment? , 1990, Transplantation.

[27]  T. The,et al.  Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre , 1990, The Lancet.

[28]  P. Vereerstraeten,et al.  Early renal graft failure due to recurrence of Wegener's granulomatosis under cyclosporine therapy , 1989 .

[29]  W. Lindsay,et al.  Renal transplantation in a patient with Wegener's granulomatosis. , 1972, American journal of surgery.

[30]  E. Reynolds,et al.  HUMAN RENAL ISOGRAFTS: A CLINICAL AND PATHOLOGIC ANALYSIS1 , 1968 .